Podiatriska University of Helsinki , the Nordic region's leading educational institutions for podiatriker, has decided to bring in Lunula laser from world-leading Erchonia USA. Lunula laser treatment and the medical evidence was crucial to this decision. Focus was on wound healing, diabetic neuropathy and feet, and of course onychomycosis where the technology is well-tested with about 90% efficiency without side effects.

Great interest from students

There was great interest and of course play both results as such the Ricardo River Podiatrist in Stockholm, has experienced big part. Arch of Scandinavia, which are working to develop this market are very grateful for this development, and hope that in the future be an integral part of medical care.

- We are very grateful that we can have a voice, to have the opportunity to not only sell a box of function, but also as a business partner, helping with implementation, business development. We do it together, transparent, and with a purpose. Many thanks to all involved, says Gilbert Holmgren, COO of the Arch of Scandinavia AB.

Many subjects treated

We now have a hundred double-blind, placebo-controlled, randomized, multi-centered studies behind the 17st FDA 510k and the results that we daily experience in all clinics around the world. In podiatry specifically, it famförallt pathogens and microcirculation that has been the focus. Onychomycosis which in the clinical studies and the results of by hundreds of clinics in Europe fought in four treatments a'12min, unsupervised, painless and without side effects.

In recent years, we have focused heavily on diabetes care. Bla blood Doppler studies that we've done in diabetics indicate a 75% increase in the microcirculation of the feet after 4 treatments in 4 weeks. What can it do for example. amputations statistics? 

Reports from the country's clinics

We receive reports regularly from the different clinics around the country, and common to all is their attempt to get care centers and primary care to take the form of treatment. The medical foot care are working with Lunulan and seeing these results know what this would do for example diabetics who face the risk of amputation. 

Here is one of the many emails we received from the medical foot-care industry, this Marien Kuiper on Foot complete Kristianstad. 

- Right now I have a type 1 diabetic client diabetes since she was 8 years old. She has disease outcomes such as reduced sensation and nerve pain in the feet. She has Charcoal feet and orthopedic shoes and inserts. She also had cracks in the heel which were difficult to heal, Säge r Marien and continues.  Lunulas laser per foot, 3 times a week for 2 weeks. Her cracks have healed and she is overjoyed because she has got so much more feeling in the feet. She feels lighter on your feet and feels them as she goes.

- I wrote a paper specifically on the effects Lunulalaser may have (not as nail fungus treatment) but to increase micro circulation, etc., which she took him to his diabetes clinic. Doctor and Nurse noted that customer's toes were much more pink, warmer, better circulating. If we in Sweden would be able to work with these diabetes clinics, educating them to take them into Lunulan, it would have been a great opportunity for diabetes! 

Reduced risk of amputation

The gist of recent experience and studies,It reduces pain and wounds and increases the patient's ability to feel their feet, and with increased microcirculation will reduce the risk of amputation.